Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women. Academic Article uri icon

Overview

abstract

  • Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance. We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.

publication date

  • April 12, 2013

Identity

PubMed Central ID

  • PMC4381746

Scopus Document Identifier

  • 84949122362

Digital Object Identifier (DOI)

  • 10.1093/jpids/pit019

PubMed ID

  • 25844164

Additional Document Info

volume

  • 3

issue

  • 3